VC Split Rock backs off of med tech investing

Venture capital outfit Split Rock Partners is planning to abandon the medical device industry, Forbes reports, looking to ditch healthcare investments and refocus on Internet services. The generalist investor has long diversified its bets across the technology space, but Managing Director Michael Gorman told Forbes that the challenging market for med tech has made the sector less attractive. Split Rock's healthcare portfolio includes Ardian, Santarus and Twelve. Article

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.